Treatment of antibiotic-resistant bacteria colonizing diabetic foot ulcers by OLED induced antimicrobial photodynamic therapy (2023)

Peer-Reviewed Study · Piksa M; Fortuna W; Lian C; Gacka M; Samuel IDW; Matczyszyn K; Pawlik KJ · August 28, 2023

Piksa M et al., 2023-08-28: Polish ex vivo study on 32 clinical bacterial strains from ten diabetic foot ulcers (22 species, 74% antibiotic-resistant): OLED light with 16 microM methylene blue reduced bacteria by 0.4 to more than 8 log, including a 5-log reduction in MRSA.

All strains were subjected to the APDT procedure using an OLED as a light source and 16 µM methylene blue as a photosensitizer.

Abstract

Piksa M et al., 2023-08-28: Polish ex vivo study on 32 clinical bacterial strains from ten diabetic foot ulcers (22 species, 74% antibiotic-resistant): OLED light with 16 microM methylene blue reduced bacteria by 0.4 to more than 8 log, including a 5-log reduction in MRSA. Study type: ex vivo (clinical wound-swab isolates; mass-spectrometry identification and antibiotic susceptibility testing). N=10 patients, 32 strains. MB 16 uM with an OLED light source; light dose not stated in the abstract. Countries: Poland (Warsaw) and UK (St Andrews). Conflicts (declared): 'IDWS is a founder and shareholder of Lustre Skin Ltd which sells products for skincare, including a wearable light source for the treatment of acne.' Bearing: supports the resistant-organism use too (see C9), but it is a laboratory study on swabs, not wound treatment. Study type: lab.